Ttbio Corp.
Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and the United States. The company offers high and low-speed hand piece products, dental spare parts, service rotors, maintenance units, electric hand piece systems, and precision-machined components. It serves various industries, including medical, automotive, aerospace, security, computer compone… Read more
Market Cap & Net Worth: Ttbio Corp. (6493)
Ttbio Corp. (TWO:6493) has a market capitalization of $23.66 Million (NT$782.80 Million) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #32645 globally and #1881 in its home market, demonstrating a -9.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ttbio Corp.'s stock price NT$26.05 by its total outstanding shares 30050000 (30.05 Million).
Ttbio Corp. Market Cap History: 2026 to 2026
Ttbio Corp.'s market capitalization history from 2026 to 2026. Data shows growth from $23.66 Million to $23.66 Million (0.00% CAGR).
Ttbio Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ttbio Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6493 by Market Capitalization
Companies near Ttbio Corp. in the global market cap rankings as of March 19, 2026.
Key companies related to Ttbio Corp. by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
Ttbio Corp. Historical Marketcap From 2026 to 2026
Between 2026 and today, Ttbio Corp.'s market cap moved from $23.66 Million to $ 23.66 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$23.66 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Ttbio Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $23.66 Million USD |
| MoneyControl | $23.66 Million USD |
| MarketWatch | $23.66 Million USD |
| marketcap.company | $23.66 Million USD |
| Reuters | $23.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.